Robyn Mitchell, Diane Lee, Linda Pelude, Jeannette Comeau, John Conly, Chelsey Ellis, Jennifer Ellison, John Embil, Gerald Evans, Lynn Johnston, Jennie Johnstone, Kevin Katz, Pamela Kibsey, Bonita Lee, Marie-Astrid Lefebvre, Yves Longtin, Allison McGeer, Dominik Mertz, Jessica Minion, Stephanie Smith, Jocelyn Srigley, Kathryn Suh, Jen Tomlinson, Alice Wong, Nisha Thampi, Charles Frenette
BACKGROUND: Recent studies have demonstrated the effectiveness of nirmatrelvir-ritonavir in reducing the risk of progression to severe disease among outpatients with mild to moderate coronavirus disease 2019 (COVID-19); however, data are limited regarding the use and role of nirmatrelvir-ritonavir among hospitalized patients. This study describes the use and outcomes of nirmatrelvir-ritonavir among adults hospitalized with COVID-19 in a sentinel network of Canadian acute care hospitals during the Omicron variant phase of the pandemic...
August 1, 2023: Canada Communicable Disease Report